Comparison of intravenous to oral trovafloxacin vs intravenous imipenem/cilastatin to oral amoxicillin/clavulanic acid in complicated intra-abdominal infections

被引：1
|
作者：
Luke, DR [1 ]
机构：
[1] Pfizer Inc, Pfizer Cent Res, Groton, CT 06340 USA
来源：
DRUGS | 1999年 / 58卷 / Suppl 2期
关键词：
D O I：
10.2165/00003495-199958002-00099
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：295 / 297
页数：3
相关论文
共 50 条
  • [21] Oral and intravenous fosfomycin in complicated urinary tract infections
    Lopez-Montesinos, Inmaculada
    Horcajada, Juan P.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019, 32 : 37 - 44
  • [22] Oral bioavailability and pharmacokinetic profile of the amoxicillin-clavulanic acid combination after intravenous and oral gavage administration in broiler chickens
    Jerzsele, A.
    Nagy, G.
    Lehel, J.
    Semjen, G.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2009, 32 (05) : 506 - 509
  • [23] The bioavailability and pharmacokinetics of an amoxicillin-clavulanic acid granular combination after intravenous and oral administration in swine
    Sun, Pan
    Zhao, Tingting
    Xiao, Hongzhi
    Wang, Jie
    Zhang, Suxia
    Cao, Xingyuan
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2021, 44 (01) : 126 - 130
  • [24] A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China
    Chen, Yijian
    Zhu, Demei
    Zhang, Yingyuan
    Zhao, Yongjie
    Chen, Gang
    Li, Ping
    Xu, Lihong
    Yan, Ping
    Hickman, M. Anne
    Xu, Xiajun
    Tawadrous, Margaret
    Wible, Michele
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 2327 - 2339
  • [25] The role of oral antimicrobials for the management of intra-abdominal infections
    Solomkin, JS
    Dellinger, P
    Bohnen, JM
    Rostein, OD
    NEW HORIZONS-THE SCIENCE AND PRACTICE OF ACUTE MEDICINE, 1998, 6 (02): : S46 - S52
  • [26] A Randomized Prospective Study of Cefepime Plus Metronidazole with Imipenem-Cilastatin in the Treatment of Intra-abdominal Infections
    J. Garbino
    P. Villiger
    A. Caviezel
    R. Matulionyte
    I. Uckay
    P. Morel
    D. Lew
    Infection, 2007, 35
  • [27] Cost Effectiveness of Ciprofloxacin plus Metronidazole versus Imipenem-Cilastatin in the Treatment of Intra-Abdominal Infections
    Daniel J. Walters
    Joseph S. Solomkin
    Joseph A. Paladino
    PharmacoEconomics, 1999, 16 : 551 - 561
  • [28] A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections
    Garbino, J.
    Villiger, P.
    Caviezel, A.
    Matulionyte, R.
    Uckay, I.
    Morel, P.
    Lew, D.
    INFECTION, 2007, 35 (03) : 161 - 166
  • [29] Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections
    Walters, DJ
    Solomkin, JS
    Paladino, JA
    PHARMACOECONOMICS, 1999, 16 (05) : 551 - 561
  • [30] Susceptibility of anaerobic flora recovered from complicated intra-abdominal infections to clinafloxacin and imipenem
    Hopkins, JA
    Wilson, SE
    Shimabukuro, J
    Chavez, C
    ANAEROBE, 1999, 5 (3-4) : 435 - 437
12345